Transcat, Inc. (NASDAQ:TRNS) Holdings Raised by Bessemer Group Inc.

Bessemer Group Inc. lifted its stake in Transcat, Inc. (NASDAQ:TRNSFree Report) by 1,692.4% in the fourth quarter, HoldingsChannel reports. The firm owned 109,608 shares of the scientific and technical instruments company’s stock after purchasing an additional 103,493 shares during the period. Bessemer Group Inc.’s holdings in Transcat were worth $11,590,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Jones Financial Companies Lllp lifted its stake in Transcat by 686.7% during the fourth quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company’s stock valued at $37,000 after buying an additional 309 shares in the last quarter. Principal Financial Group Inc. lifted its position in shares of Transcat by 8.8% in the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company’s stock valued at $557,000 after acquiring an additional 373 shares in the last quarter. Victory Capital Management Inc. lifted its position in shares of Transcat by 1.4% in the 4th quarter. Victory Capital Management Inc. now owns 34,710 shares of the scientific and technical instruments company’s stock valued at $3,670,000 after acquiring an additional 480 shares in the last quarter. Rhumbline Advisers boosted its stake in Transcat by 4.1% in the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company’s stock worth $1,306,000 after purchasing an additional 486 shares during the period. Finally, Janus Henderson Group PLC grew its position in Transcat by 4.5% during the 3rd quarter. Janus Henderson Group PLC now owns 13,941 shares of the scientific and technical instruments company’s stock worth $1,684,000 after purchasing an additional 606 shares in the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Insider Transactions at Transcat

In other Transcat news, Director Craig D. Cairns acquired 1,200 shares of Transcat stock in a transaction that occurred on Friday, January 31st. The stock was acquired at an average price of $77.02 per share, with a total value of $92,424.00. Following the purchase, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. This trade represents a 169.01 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. HC Wainwright reduced their target price on Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a report on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and issued a $85.00 price objective (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Oppenheimer cut Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th. Finally, Craig Hallum boosted their price objective on shares of Transcat from $113.00 to $125.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $111.50.

Get Our Latest Report on Transcat

Transcat Stock Performance

Shares of NASDAQ TRNS opened at $77.24 on Friday. Transcat, Inc. has a one year low of $67.56 and a one year high of $147.12. The business’s 50-day moving average price is $76.40 and its two-hundred day moving average price is $97.15. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98. The company has a market capitalization of $719.03 million, a P/E ratio of 41.75 and a beta of 0.67.

Transcat (NASDAQ:TRNSGet Free Report) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same period in the prior year, the company earned $0.56 EPS. Analysts anticipate that Transcat, Inc. will post 2.3 earnings per share for the current fiscal year.

About Transcat

(Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Further Reading

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNSFree Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.